SARS-CoV-2 Disguise Study

  • STATUS
    Recruiting
  • participants needed
    900
  • sponsor
    Meshalkin Research Institute of Pathology of Circulation
Send
Updated on 19 February 2024
See if I qualify
SARS
oropharyngeal
coronavirus infection
acute respiratory syndrome (sars)

Summary

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a pandemic disease with worldwide spreading. Limited data are existed regarding SARS-CoV-2 positive carriers among asymptomatic medical employees in non-profile infectious clinic, e.g. cardiovascular clinic, routinely working in the pandemic region with two million inhabitants. The aim is to test the percentage and increase of the SARS-CoV-2 positive carriers among asymptomatic medical employees in high-volume cardiovascular center in routine clinical practice.

Details
Condition Sars-CoV2
Age 18years - 100years
Treatment SARS-CoV-2-test, SARS-CoV-2 questionnaire survey
Clinical Study IdentifierNCT04395794
SponsorMeshalkin Research Institute of Pathology of Circulation
Last Modified on19 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

Asymptomatic medical employees of E. Meshalkin National Medical Research Center of the Ministry of Health of the Russian Federation
Filled questionnaire before SARS-CoV-2 testing
Nasopharyngeal and oropharyngeal testing for SARS-CoV-2
Signed informed consent

Exclusion Criteria

Unwilling to participate
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

SARS
oropharyngeal
coronavirus infection
acute respiratory syndrome (sars)

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.